Insights

Award-Winning Recognition Talking Medicines has been awarded the Gold Winner at the PM360 Trailblazer Awards 2023 for its innovative AI and data analytics initiatives. This recognition highlights the company's expertise and differentiation in the pharmaceutical industry, creating a sales opportunity by leveraging this prestigious accolade to attract more clients.

Strategic Expansion With recent funding of $2.04M and a focus on expanding into the US market, Talking Medicines is poised for growth. Sales development representatives can capitalize on this expansion plan to target potential clients in the US pharmaceutical sector, offering them unique AI-driven patient intelligence solutions.

Key Personnel Addition The appointment of Mike Strassberg as Chief Customer Officer indicates a strategic move towards enhancing customer relationships. This presents a sales opportunity to leverage Mike's expertise and networks to drive customer acquisition and retention, positioning Talking Medicines as a customer-centric solution provider.

Academic Thought Leadership The publication of an academic paper showcasing Talking Medicines' methodologies signifies thought leadership in the industry. Sales professionals can use this academic credibility to engage with clients looking for cutting-edge solutions based on robust research and data-driven insights, enhancing the company's sales proposition.

Innovative Technology Stack Talking Medicines utilizes advanced technologies like Google Ads, Cloudflare CDN, and Large Language Models in its AI platform, demonstrating a tech-savvy approach. Sales development representatives can highlight this tech stack advantage to position the company as a forward-thinking partner for pharmaceutical clients seeking innovative digital solutions.

Talking Medicines Tech Stack

Talking Medicines uses 8 technology products and services including Google Ads, Cloudflare CDN, Twitter Emoji (Twemoji), and more. Explore Talking Medicines's tech stack below.

  • Google Ads
    Advertising
  • Cloudflare CDN
    Content Delivery Network
  • Twitter Emoji (Twemoji)
    Font Scripts
  • jQuery
    Javascript Libraries
  • HTTP/3
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Piwik
    System Analytics & Monitoring
  • MediaElement.js
    Video Players

Media & News

Talking Medicines's Email Address Formats

Talking Medicines uses at least 1 format(s):
Talking Medicines Email FormatsExamplePercentage
First@talkingmedicines.comJohn@talkingmedicines.com
87%
Last@talkingmedicines.comDoe@talkingmedicines.com
8%
FirstLast@talkingmedicines.comJohnDoe@talkingmedicines.com
2%
First.Last@talkingmedicines.comJohn.Doe@talkingmedicines.com
3%

Frequently Asked Questions

Where is Talking Medicines's headquarters located?

Minus sign iconPlus sign icon
Talking Medicines's main headquarters is located at 95 Christopher Columbus Dr Floor 16 Jersey City, New Jersey 07302 US. The company has employees across 2 continents, including EuropeNorth America.

What is Talking Medicines's official website and social media links?

Minus sign iconPlus sign icon
Talking Medicines's official website is talkingmedicines.com and has social profiles on LinkedIn.

How much revenue does Talking Medicines generate?

Minus sign iconPlus sign icon
As of August 2023, Talking Medicines's annual revenue reached $3.8M.

What is Talking Medicines's NAICS code?

Minus sign iconPlus sign icon
Talking Medicines's NAICS code is 5112 - Software Publishers.

How many employees does Talking Medicines have currently?

Minus sign iconPlus sign icon
As of August 2023, Talking Medicines has approximately 42 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer, Founder: J. H.Head Of Product (consultant): K. S.Chairman: A. S.. Explore Talking Medicines's employee directory with LeadIQ.

What industry does Talking Medicines belong to?

Minus sign iconPlus sign icon
Talking Medicines operates in the Software Development industry.

What technology does Talking Medicines use?

Minus sign iconPlus sign icon
Talking Medicines's tech stack includes Google AdsCloudflare CDNTwitter Emoji (Twemoji)jQueryHTTP/3Open GraphPiwikMediaElement.js.

What is Talking Medicines's email format?

Minus sign iconPlus sign icon
Talking Medicines's email format typically follows the pattern of . Find more Talking Medicines email formats with LeadIQ.

How much funding has Talking Medicines raised to date?

Minus sign iconPlus sign icon
As of August 2023, Talking Medicines has raised $2M in funding. The last funding round occurred on Feb 01, 2022 for $2M.

When was Talking Medicines founded?

Minus sign iconPlus sign icon
Talking Medicines was founded in 2013.
Talking Medicines

Talking Medicines

Software DevelopmentNew Jersey, United States11-50 Employees

Talking Medicines is revolutionising the pharmaceutical industry and the $30Bn it spends on advertising with its innovative data science platform.  By harnessing the power of artificial intelligence (AI) and natural language processing (NLP), the platform transforms unstructured social feedback from patients, Health Care Professionals (HCPs) , Key Opinion Leaders (KOL) and Digital Opinion Leaders (DOL) for advertising agencies and their pharmaceutical clients. Using Large Language Models within its advanced AI, clients can answer questions through its Drug-GPT™ of the highly curated and classified healthcare voices to find a single source of truth about lived experience.  This allows companies to deliver a greater return on investment for marketing and improves health outcomes for patients. With the data science of Talking Medicines, advertising agencies have access to a scale and depth of insights that was previously impossible, enabling them to make data-driven decisions that drive success. Real time access through SaaS platform PatientMetRx® or configured through data science as a service.

Section iconCompany Overview

Headquarters
95 Christopher Columbus Dr Floor 16 Jersey City, New Jersey 07302 US
NAICS Code
5112 - Software Publishers
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $2M

    Talking Medicines has raised a total of $2M of funding over 4 rounds. Their latest funding round was raised on Feb 01, 2022 in the amount of $2M.

  • $10M

    Talking Medicines's revenue is in the range of $10M

Section iconFunding & Financials

  • $2M

    Talking Medicines has raised a total of $2M of funding over 4 rounds. Their latest funding round was raised on Feb 01, 2022 in the amount of $2M.

  • $10M

    Talking Medicines's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.